CONFIDE
Overview
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study was an online, quantitative, cross-sectional survey of healthcare providers (HCPs) and patients, aiming to provide further understanding of the burden, barriers, and care experience of those living with inflammatory bowel disease (IBD), as well as to elucidate gaps in communication between HCPs and patients1,2
This study was sponsored by Eli Lilly and Company.
Survey Development
CONFIDE gastroenterologist advisory panel (n=6) input on the HCP and patient surveys
In parallel, patients with UC (n=3) and CD (n=2) gave input on the patient survey
Adelphi Real World conducted further review sessions with additional gastroenterologists (n=2) and patients (n=2) in both the US and the UK to further test the validity of the materials prior to the CONFIDE survey launch.
Key eligibility criteria for HCPs:1
A gastroenterologist, internal medicine physician with GI focus, IBD nurse specialist, nurse practitoner, or physician assistant.
Responsible for making prescribing decisions for at least 10 patients with UC/CD, of which at least 5 of whom must be patients with moderate-to-severe UC and CD in a month.
Spending 50% or more of working time actively seeing patients.
Key eligibility criteria for patients:1
Aged ≥ 18 years.
UC or CD diagnosed by an HCP (as reported by the patient).
Active disease of at least moderate severity as defined by meeting ≥ 1 of the following criteria:
- Received TNFi, anti-integrin, JAKi, IL-12/23i or immunomoduloator within the last 12 months
- duration of steriod treatment of at least one month out fo the last 12 months
- Hospitalized for at least 4 consecutive weeks in the last 5 years
No previous colectomy
Survey administration
Online survey:
- Demographic/background information
- Symptom experience and impact
- Disease burden
- HCP-Patient communication
Related resources
Communicating Needs and Features of IBD Experiences (CONFIDE) Study: Key results for US patients with ulcerative colitis
This infographic summarizes the key results of the CONFIDE study for patients with moderate-to-severe ulcerative colitis in the United States.
Communicating Needs and Features of Inflammatory Bowel Disease Experiences (CONFIDE) Study Summary
This infographic summarizes the background, development, and design of the CONFIDE study.
References
- Rubin DT, Panaccione R, Potts Bleakman A, et al. P028 Communicating needs and features of IBD experiences (CONFIDE) Survey: Patient and health care professional perspectives on experience of ulcerative colitis symptoms. Am J Gastroenterol. 2021;116(Suppl 1):S7.
- Pannaccione R, Hibi T, Potts Bleakman A, at al. Mo1079 Communicating needs and features of IBD experiences (CONFIDE) survey: Impact of ulcerative colitis on health care professional treatment decisions. Gastroenterology. 2022;162(7):S-688.
VV-MED-134811